Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates

Figure 3

Percentage changes in bone mineral density (BMD) of the femoral neck measured by dual-energy x-ray absorptiometry (DXA) at 6, 12 and 18 months after the start of treatment in the bisphosphonate (Bis) and Bis + statin groups. Circles represent the Bis group and triangles represent the Bis + statin group. Significant decreases in BMD of the femoral neck were observed at 6 and 18 months in the Bis group, but in the Bis + statin group a significant decrease in BMD was not observed during the follow-up period. *P < 0.05, **P < 0.01, for comparison to baseline for each group.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us